PubMed Health⌕ Search

Biomedical subjects

Y Z Sheu

Publications and source records attributed to Y Z Sheu.

2 recordsLinked to original sources

Differential modulation by basilar and mesenteric endothelium of angiotensin-induced contraction in canine arteries.

The contraction of ring segments of canine mesenteric and basilar arteries in response to angiotensins II and III was investigated. Removal of the mesenteric endothelium resulted in markedly intensified contraction in response to angiotensin II but did not affect the contractile response to angiotensin III. This angiotensin II-induced contraction was augmented by indomethacin (10(-5) M) and by methylene blue (5 X 10(-6) M) in the intact rings. These findings suggest that mesenteric endothelium modulates the vasoconstriction induced by angiotensin II but not that induced by angiotensin III. They also indicate that the mesenteric endothelium may contain relaxing factors such as prostacyclin or endothelium-derived relaxing factor as mediators. In contrast with mesenteric endothelium, removal of the basilar endothelium produced a much reduced contraction in response to either angiotensin. Acetylcholine, which caused a dose-dependent contraction in the basilar artery, elicited only a low-grade response if the functional endothelium was absent. These results suggest that basilar endothelium may release a contracting factor. It is possible that the main modulator of the peripheral arteries is a relaxing factor but that of the cerebral arteries is a contracting factor.

Acetylcholine↗

17-beta-Hydroxysteroid dehydrogenase in rabbit bone marrow.

Because of the general presence of 17-B-hydroxysteroid dehydrogenase (17-B-HSD) in animals and human erythrocytes, it is very likely that this enzyme is also present in the erythrocyte precursor cells in bone marrow. Adult male white New Zealand rabbits were used to demonstrate the existence of the 17-B-HSD in bone marrow cells and to evaluate the biological function of 17-B-HSD in the erythropoietic system in bone marrow. Anemia was artificially induced in these animals in order to stimulate the proliferation of erythropoietic cells. This was accomplished by bleeding or by intra-peritoneal injection of 40 mg/kg of phenylhydrazine. The 17-B-HSD activities were then examined by histochemical and biochemical assays. The results showed a two to three-fold increase of the enzyme activities in both peripheral erythrocytes and bone marrow cells of anemic animals. Our experiments further demonstrate the fine control of erythropoiesis. The enzyme, which favors the conversion of oestradiol to oestrone, is itself boosted by an anemic state. As a result, the inhibitory action of hemopoiesis by oestradiol was relieved.

17-Hydroxysteroid Dehydrogenases↗